Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage.

Abstract

Viral envelope glycoproteins are crucial for viral infections. In the process of enveloped viruses budding and release from the producer cells, viral envelope glycoproteins are presented on the viral membrane surface as spikes, promoting the virus's next-round infection of target cells. However, the host cells evolve counteracting mechanisms in the long-term virus-host co-evolutionary processes. For instance, the host cell antiviral factors could potently suppress viral replication by targeting their envelope glycoproteins through multiple channels, including their intracellular synthesis, glycosylation modification, assembly into virions, and binding to target cell receptors. Recently, a group of studies discovered that some host antiviral proteins specifically recognized host proprotein convertase (PC) furin and blocked its cleavage of viral envelope glycoproteins, thus impairing viral infectivity. Here, in this review, we briefly summarize several such host antiviral factors and analyze their roles in reducing furin cleavage of viral envelope glycoproteins, aiming at providing insights for future antiviral studies.

• Authors: Changqing Yu, Guosheng Wang, Qiang Liu, Jingbo Zhai, Mengzhou Xue, Qiang Li, Yuanhua Xian, Chunfu Zheng
• Journal: Emerging microbes & infections (Emerg Microbes Infect) Vol. 12 Issue 1 Pg. 2164742 (Dec 2023) ISSN: 2222-1751 [Electronic] United States
• PMID: 36591809 (Publication Type: Review, Journal Article)

Chemical References

• Furin
• Viral Envelope Proteins
• Antiviral Agents
• Glycoproteins

Topics

• Humans
• Furin (metabolism)
• Viral Envelope Proteins (metabolism)
• SARS-CoV-2 (metabolism)
• Ebolavirus
• HIV-1
• Antiviral Agents (pharmacology)
• Hemorrhagic Fever, Ebola
• COVID-19
• Glycoproteins
• Virus Diseases